New evidence-based diagnostic and management strategies for placenta accreta spectrum disorders
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
The increasing incidence of caesarean delivery (CD) has resulted in a rise in placenta accreta spectrum (PAS), adversely impacting maternal outcomes globally. Currently, more than 90% of women diagnosed with PAS present with a placenta previa (previa PAS). Previa PAS can be reliably diagnosed antenatally with ultrasound, it is unclear if magnetic resonance imaging improves diagnosis beyond what can be achieved by skilled ultrasound operators. Therefore, any screening programme for PAS will require improved training in diagnosis of placental disorders and development of targeted scanning protocols. Management strategies for previa PAS vary depending on the accuracy of prenatal diagnosis, findings at laparotomy and local surgical expertise. Current epidemiological data for PAS are highly heterogeneous, mainly due to wide variation in the clinical criteria used to diagnose the condition at birth. This significantly impacts research into all aspects of the condition but especially comparison of the efficacy of different management strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maternal Morbidity Associated With Multiple Repeat Cesarean Deliveries
Silver, R. M., Landon, M. B., Rouse, D. J., Leveno, K. J., Spong, C. Y., Thom, E. A., Moawad, A. H., Caritis, S. N., Harper, M., Wapner, R. J., et al. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000219750.79480.84 · Cited by 1,909
Jauniaux, E., Collins, S., & Burton, G. J. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.05.067 · Cited by 775 · cited 1×
“in pregnancies without evidence of PAS (50).”
Self-citationFIGO classification for the clinical diagnosis of placenta accreta spectrum disorders,
Jauniaux, E., Ayres‐de‐Campos, D., Langhoff‐Roos, J., Fox, K. A., Collins, S., & Panel, F. P. A. D. A. M. E. C. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12761 · Cited by 668
Self-citationThe management of placenta percreta: Conservative and operative strategies
O'Brien, J. M., Barton, J. R., & Donaldson, E. S. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70117-5 · Cited by 625
Impact of multiple cesarean deliveries on maternal morbidity: a systematic review
Marshall, N. E., Fu, R., & Guise, J.-M. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.06.035 · Cited by 565 · cited 6×
“The absence of ultrasound findings does not preclude the diagnosis of PAS (especially abnormally adherent placenta) and clinical factors (CDs and placenta previa) remain important in identifying women at high-risk (7,8).”
BackgroundInfluentialCenter of excellence for placenta accreta
Silver, R. M., Fox, K. A., Barton, J. R., Abuhamad, A. Z., Simhan, H., Huls, C. K., Belfort, M. A., & Wright, J. D. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.11.018 · Cited by 518
Self-citationSilver, R. M., & Branch, D. W. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1709324 · Cited by 511 · cited 2×
“(52) recently proposed methods for gross dissection, microscopic examination and reporting of hysterectomy specimens containing PAS.”
BackgroundPlacenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a
Jauniaux, E., Alfirevic, Z., Bhide, A., Belfort, M., Burton, G., Collins, S., Dornan, S., Jurkovic, D., Kayem, G., Kingdom, J., et al. (2019) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15306 · Cited by 506
Self-citationShamshirsaz, A. A., Fox, K. A., Salmanian, B., Diaz-Arrastia, C. R., Lee, W., Baker, B. W., Ballas, J., Chen, Q., Van Veen, T. R., Javadian, P., et al. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.08.019 · Cited by 478
Self-citationFitzpatrick, K. E., Sellers, S., Spark, P., Kurinczuk, J. J., Brocklehurst, P., & Knight, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052893 · Cited by 463 · cited 1×
“7 per 10,000 to 577 per 10,000 births in women presenting with a placenta previa and a prior CD (19).”
BackgroundPlacenta accreta: Pathogenesis of a 20th century iatrogenic uterine disease
Jauniaux, E., & Jurkovic, D. (2012) · Placenta · doi:10.1016/j.placenta.2011.11.010 · Cited by 432 · cited 2×
“PAS is primarily a consequence of modern obstetric and reproductive practices, and is likely to become increasingly common as women delay childbearing, require reproductive assistance and enter pregnancy with medical co-morbidities (25).”
BackgroundSelf-citationThe association of placenta previa with history of cesarean delivery and abortion: A metaanalysis
Ananth, C. V., Smulian, J. C., & Vintzileos, A. M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70017-6 · Cited by 361
Fitzpatrick, K., Sellers, S., Spark, P., Kurinczuk, J., Brocklehurst, P., & Knight, M. (2014) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12405 · Cited by 357 · cited 2×
“However, recent population studies have shown that PAS remains undetected before delivery in half (53,57) to two-third of”
BackgroundJauniaux, E., & Bhide, A. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.02.050 · Cited by 348 · cited 2×
“Currently, more than 90% of women diagnosed with PAS also have a placenta previa (20), the combination of both conditions leads to high maternal morbidity and mortality due to massive haemorrhage at the time of birth (21,22).”
BackgroundSelf-citationProposal for standardized ultrasound descriptors of abnormally invasive placenta ( AIP )
Collins, S. L., Ashcroft, A., Braun, T., Calda, P., Langhoff‐Roos, J., Morel, O., Stefanovic, V., Tutschek, B., Chantraine, F., & on behalf of the European Working Group on Abnormally Invasive Placenta (EW‐AIP) (2016) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14952 · Cited by 331
Self-citationFIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management,
Sentilhes, L., Kayem, G., Chandraharan, E., Palacios‐Jaraquemada, J., Jauniaux, E., & Panel, F. T. F. P. A. D. A. M. E. C. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12410 · Cited by 322
Self-citationSolheim, K. N., Esakoff, T. F., Little, S. E., Cheng, Y. W., Sparks, T. N., & Caughey, A. B. (2011) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.553695 · Cited by 320 · cited 1×
“mortality of placenta previa with percreta has been reported to be as high as 7% of cases (23).”
BackgroundMorbidly Adherent Placenta Treatments and Outcomes
Bailit, J. L., Grobman, W. A., Rice, M. M., Reddy, U. M., Wapner, R. J., Varner, M. W., Leveno, K. J., Iams, J. D., Tita, A. T. N., Saade, G., et al. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000680 · Cited by 313
Shamshirsaz, A. A., Fox, K. A., Erfani, H., Clark, S. L., Salmanian, B., Baker, B. W., Coburn, M., Shamshirsaz, A. A., Bateni, Z. H., Espinoza, J., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.02.016 · Cited by 230
Self-citationRisk factors for placenta accreta: a large prospective cohort
Eller, A., Bardsley, T., Greene, T., Varner, M., Silver, R., & Bowman, Z. (2013) · American Journal of Perinatology · doi:10.1055/s-0033-1361833 · Cited by 224
Jauniaux, E., Collins, S. L., Jurkovic, D., & Burton, G. J. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.07.044 · Cited by 208
Self-citationPlacenta accreta and the risk of adverse maternal and neonatal outcomes
Balayla, J., & Bondarenko, H. D. (2013) · jpme · doi:10.1515/jpm-2012-0219 · Cited by 128
Einerson, B. D., Rodriguez, C. E., Kennedy, A. M., Woodward, P. J., Donnelly, M. A., & Silver, R. M. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.03.013 · Cited by 121 · cited 1×
“cases, but when changed, the diagnosis was often incorrect (69).”
BackgroundMeng, X., Xie, L., & Song, W. (2013) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2013.05.017 · Cited by 118 · cited 1×
“placentation and that ultrasound and MRI have comparable predictive parameters (67,68).”
BackgroundGreen, L., Knight, M., Seeney, F., Hopkinson, C., Collins, P., Collis, R., Simpson, N., Weeks, A., & Stanworth, S. (2016) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13831 · Cited by 117
Mehrabadi, A., Hutcheon, J. A., Liu, S., Bartholomew, S., Kramer, M. S., Liston, R. M., & Joseph, K. S. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000722 · Cited by 112
Tam Tam, K. B., Dozier, J., & Martin, J. N. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.576720 · Cited by 102
PAMUS: placenta accreta management across the United States
Esakoff, T. F., Handler, S. J., Granados, J. M., & Caughey, A. B. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.598585 · Cited by 82
Bartels, H. C., Rogers, A. C., O’Brien, D., McVey, R., Walsh, J., & Brennan, D. J. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002865 · Cited by 67
Practice patterns and knowledge of obstetricians and gynecologists regarding placenta accreta
Wright, J. D., Silver, R. M., Bonanno, C., Gaddipati, S., Lu, Y.-S., Simpson, L. L., Herzog, T. J., Schulkin, J., & D’Alton, M. E. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.793662 · Cited by 67 · cited 2×
“survey of experts found that 61% opt for a primary PH with the placenta left in situ as their first-choice management approach (74).”
BackgroundBrookfield, K. F., Goodnough, L. T., Lyell, D. J., & Butwick, A. J. (2014) · Transfusion · doi:10.1111/trf.12483 · Cited by 54
Cal, M., Ayres‐de‐Campos, D., & Jauniaux, E. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12391 · Cited by 48
Self-citationSystematic review of uterus-preserving treatment modalities for abnormally invasive placenta
Mei, J., Wang, Y., Zou, B., Hou, Y., Ma, T., Chen, M., & Xie, L. (2015) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2015.1011106 · Cited by 41 · cited 1×
“and that use of ureteric stents reduces the risk of urologic injury (79).”
BackgroundZosmer, N., Jauniaux, E., Bunce, C., Panaiotova, J., Shaikh, H., & Nicholaides, K. H. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12389 · Cited by 31
Self-citationSargent, W., & Collins, S. L. (2019) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.13487 · Cited by 21
Self-citation
Cited by
Hecht, J. L., Baergen, R., Ernst, L. M., Katzman, P. J., Jacques, S. M., Jauniaux, E., Khong, T. Y., Metlay, L. A., Poder, L., Qureshi, F., et al. (2020) · Modern Pathology · doi:10.1038/s41379-020-0569-1 · Cited by 263
Self-citationChu, C., Liu, M., Zhang, Y., Zhao, S., Ge, Y., Li, W., & Gao, C. (2022) · Diagnostics · doi:10.3390/diagnostics12020485 · Cited by 12
Guo, C., Guo, S., He, C., Zhang, X., Han, D., Tan, H., Huang, X., & Li, Y. (2025) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-025-07960-5 · Cited by 4
“Placenta accreta spectrum disorders (PAS) encompass a range of conditions characterized by abnormal placental attachment to the uterine wall, including placenta accreta, placenta increta, and placenta percreta [1, 2].”
Machine Learning in Maternity: Early Diagnosis of Placenta Accreta Spectrum
Waszczuk, D., Manikandan, V., Wong, B. L., Martin, F., Bhargava, N., Mondal, A., Loy, M., Strnad, D., Panchatcharam, M., Sadanala, G., et al. (2026) · Cureus · doi:10.7759/cureus.106592
Metadata
- Authors
- Jauniaux, E., Hussein, A. M., Fox, K. A., & Collins, S. L.
- Venue
- Best Practice & Research Clinical Obstetrics & Gynaecology
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 61
- Pages
- 75-88
- ISSN
- 1521-6934 (ISSN-L)
- OpenAlex
- W2942934263
- Cited by
- 110
- References
- 35
- FWCI
- 10.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.